Here’s what you should know:
1. Cantel’s sales increased 13.3 percent year-over-year, with organic sales increasing 8.6 percent.
2. Cantel reported diluted earnings per share of $0.55, which was up 21.9 percent year-over-year.
3. The company’s endoscopy sales grew 19.8 percent year-over-year while recurring revenue for the segment increased 20.8 percent.
4. Cantel also closed its acquisition of BHT Group during the quarter. BHT is the German leader in automated endoscope reprocessing.
5. Cantel Medical President and CEO Jørgen B. Hansen said Cantel was pleased to report “record sales and earning performance this quarter.”
More articles on gastroenterology:
Colonoscopy physician fees for 30 largest cities — Milwaukee No. 1 at $882
Mayo Clinic, Digestive and Liver Disease Consultants & more: 9 GI practices in the news
Lumendi’s DiLumen completes 100th procedure — 4 insights
